Cardiorenal Syndrome

My Settings
Relevant Content
Researchers at Heart
Intrarenal Determinants of GFR Decline During Loop Diuretic Therapy
Hypertension, Volume 83, Issue 11, Page e27712, November 1, 2026.
Loo...
Methodologic Standards for Follow-Up Extension in Cardiovascular Trials
Extension follow-up studies address long-term questions beyond the parent...
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy
Polypharmacy is common in cardiovascular (CV) care because guideline-direc...
Strategies for Optimizing Heart Failure Care in the Older Adult
Heart failure (HF) in older adults is a growing and distinct clinical chal...
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
Guideline offering updated evidence on cardiovascular‑kidney‑metabolic syn...
Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease
The American Heart Association Predicting Risk of Cardiovascular Disease E...
Health Care Affordability in the United States, From Crisis to Action
U.S. health care costs exceed $5T yearly, driving delayed care and debt. E...
2026 Heart Disease and Stroke Statistics
The American Heart Association and National Institutes of Health’s 2026 St...
Pragmatic Approaches to the Evaluation and Monitoring of Artificial Intelligence in Healthcare
American Heart Association advisory outlines risk-based governance and con...